Misplaced Pages

Eperezolid: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 02:58, 5 January 2011 editPashihiko (talk | contribs)Extended confirmed users3,559 editsNo edit summary← Previous edit Latest revision as of 04:43, 25 March 2024 edit undoDMacks (talk | contribs)Edit filter managers, Autopatrolled, Administrators186,448 edits auto mw 
(28 intermediate revisions by 21 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| Verifiedfields = changed
| IUPAC_name = (''S'')-''N''-<nowiki>phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
| verifiedrevid = 406013269
| image = Eperezolid.png
| IUPAC_name = (''S'')-''N''-{{!((}}3-phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
| CAS_number = 165800-04-4
| image = Eperezolid.png
| ATC_prefix = none
| alt = Skeletal formula of eperezolid
| ATC_suffix =
| width = 260
| PubChem = 73214
| image2 = Eperezolid 3D spacefill.png
| DrugBank =
| alt2 = Space-filling model of the eperezolid molecule
| KEGG = D04017

| C = 18 | H = 23 | F = 1 | N = 4 | O = 5
<!--Clinical data-->
| molecular_weight = 394.40
| tradename =
| smiles = CC(=O)NC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| bioavailability =
| pregnancy_US = <!-- A / B / C / D / X -->
| protein_bound =
| metabolism = | pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =

| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
<!--Identifiers-->
| pregnancy_US = <!-- A / B / C / D / X -->
| CAS_number_Ref = {{cascite|correct|??}}
| pregnancy_category=
| CAS_number = 165800-04-4
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| ATC_prefix = none
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| ATC_suffix =
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| PubChem = 73214
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| legal_status =
| DrugBank =
| routes_of_administration =
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = C460ZSU1OW
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04017
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 47955
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 65969

<!--Chemical data-->
| C=18 | H=23 | F=1 | N=4 | O=5
| smiles = CC(=O)NC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C18H23FN4O5/c1-12(25)20-9-14-10-23(18(27)28-14)13-2-3-16(15(19)8-13)21-4-6-22(7-5-21)17(26)11-24/h2-3,8,14,24H,4-7,9-11H2,1H3,(H,20,25)/t14-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = SIMWTRCFFSTNMG-AWEZNQCLSA-N

}} }}


'''Eperezolid''' is an ] ]. '''Eperezolid''' is an ] ].{{cn|date=March 2023}}


==Synthesis==
]

== See also ==
*]

== References ==
{{Reflist}}
{{Protein synthesis inhibitor antibiotics}} {{Protein synthesis inhibitor antibiotics}}


] ]
] ]
] ]
] ]
] ]



{{antibiotic-stub}} {{antibiotic-stub}}

]